Humacyte: Health & Economic Perspective | Medical Office Live | March 6, 2019 | Chapel Hill, NC
38:49
Innovator, scientist and vascular surgeon, Jeff Lawson, MD, PhD, discusses the promise of regenerative medicine in transforming vascular access care and the health economic implications of Humacyl.
Innovator, scientist and vascular surgeon, Jeff Lawson, MD, PhD, discusses the promise of regenerative medicine in transforming vascular access care and the health economic implications of Humacyl.
Value Based Care | Chapel Hill, NC (March 2019) Similar Videos
-
Using Quality Data & Clinical Innovations to Improve ESCO Care | Medical Office Live | March 6, 2019 | Chapel Hill, NC
30:28
Nephrologist and value based care expert Terry Ketchersid, MD outlines the value of the transparency report and highlights clinical innovations that are driving success in value based care models.
-
Why Value-Based Care and NextGen ESCOs | Medical Office Live | March 6, 2019 | Chapel Hill, NC
21:31
Fresenius Health Partners President, William McKinney, provides an update on the current state of value based care in the renal care space and explores potential value based care models of the future and their implications for care delivery.
-
Medicare Risk Adjustment and CKD in Value Based Care | Medical Office Live | March 6, 2019 | Chapel Hill, NC
29:37
Fresenius Health Partners’ Andy Aronson unravels the mystery of Medicare risk adjustment and talks about the impact of organizing CKD care in the ESCO environment.
